admin – Page 4324 – Get News Story

Smart Aligner Services welcomes the Palatal Expander at their ‘Dental and Skeletal Expansion’ event

On February 7th and 8th, Madrid will host the highly anticipated “Dental and Skeletal Expansion” course, organized by Smart Aligner Services (SAS). This event will focus on the revolutionary application of the Palatal Expander, an innovative technique transforming maxillary expansion treatments in Europe.

The Palatal Expander: A breakthrough in orthodontics

The Palatal Expander, designed to widen the upper jaw, stands as a cutting-edge tool in modern orthodontics. With its ability to improve occlusion, promote balanced facial development, and enhance respiratory health, this device has gained widespread recognition in other parts of the world. Now, its implementation in Europe signifies a pivotal moment in orthodontic treatments.

This course, crafted and led by SAS, will offer a comprehensive perspective on this technique, highlighting its biomechanical principles, practical applications, and advantages over traditional methods. Real clinical case demonstrations will further enable attendees to fully understand its potential.

International experts and real-world cases

A major highlight of the event is the participation of the renowned Dr. Sam Lee, the surprise speaker. With extensive expertise in the use of the Palatal Expander, Dr. Lee will present clinical cases and share key strategies to maximize results across various patient profiles.

The program also features other distinguished specialists, including:

Dr. Ana Acedo: Workflow and benefits of aligners for pediatric patients.

Dr. Javier Lozano: Indications and follow-up strategies for treatments using brackets, aligners, and expanders.

Dr. Stefano Marini: Biomechanics applied to dental and skeletal expansion.

Educational content and resources

Participants will receive exclusive materials prepared by SAS, including a detailed summary of all protocols covered during the course. These documents, available in both Spanish and English, are designed to facilitate the practical implementation of the techniques learned.

The event also provides opportunities for networking, allowing attendees to interact with experts and peers, and will conclude with a special dinner for VIP and Exclusive participants.

Event details

Dates: February 7–8, 2025.

Venue: Hotel Meliá Innside Valdebebas, Madrid.

Organizer: Smart Aligner Services (SAS).

Registration Options: Regular, VIP, and Exclusive.

A unique opportunity in Europe

This course represents an unparalleled opportunity for orthodontic professionals aiming to lead advancements in maxillary expansion techniques. With the support of Smart Aligner Services (SAS) and the expertise of Dr. Sam Lee, this event is poised to become a milestone in European orthodontic education.

Media Contact
Company Name: Smart Aligner Services SL
Contact Person: Press Office
Email: Send Email
Country: Spain
Website: https://smartalignerservices.com/en/

Body Contouring Procedures in Michigan Now Offered by Aesthetic Plastic Surgery & Laser Center, Michelle Hardaway M.D.

Farmington Hills, MI – Aesthetic Plastic Surgery & Laser Center, Michelle Hardaway M.D. led by board-certified plastic surgeon Michelle Hardaway M.D., has expanded its range of body contouring services for Michigan residents. The center now offers a comprehensive suite of surgical and non-invasive body sculpting procedures designed to help patients achieve their desired physique.

Body contouring encompasses a variety of techniques aimed at reshaping and refining the body’s silhouette. Dr. Hardaway’s practice specializes in procedures such as liposuction, tummy tucks, mommy makeovers, and Brazilian butt lifts, catering to individuals seeking to enhance their appearance and boost self-confidence.

Liposuction remains one of the most popular body contouring procedures in Michigan. This surgical technique removes stubborn fat deposits from areas resistant to diet and exercise. Dr. Hardaway employs advanced liposuction methods to ensure precise fat removal and smooth, natural-looking results.

For patients dealing with excess abdominal skin and weakened muscles, often following pregnancy or significant weight loss, tummy tuck surgery (abdominoplasty) offers a solution. This procedure tightens the abdominal muscles and removes excess skin, resulting in a flatter, more toned midsection.

The mommy makeover has gained popularity among women looking to restore their pre-pregnancy figures. This customized combination of procedures typically includes breast enhancement, tummy tuck, and liposuction, addressing multiple areas of concern in a single surgical session.

Brazilian butt lift surgery has seen increased demand in recent years. This procedure involves fat transfer, taking unwanted fat from other body areas and strategically injecting it into the buttocks for enhanced shape and volume.

For patients seeking non-invasive alternatives, Aesthetic Plastic Surgery & Laser Center offers cutting-edge treatments such as CoolSculpting and skin tightening procedures. These options provide body contouring benefits without the need for surgery or extended recovery periods.

Dr. Michelle Hardaway, a Fellow of the American College of Surgeons with over two decades of experience, emphasizes the importance of personalized care in body contouring. “Each patient’s body and goals are unique,” Dr. Hardaway states. “We take a customized approach to body contouring, combining various techniques to achieve optimal results tailored to the individual’s needs and desires.”

The center’s commitment to patient safety and satisfaction is evident in its state-of-the-art facilities and comprehensive pre- and post-operative care. Dr. Hardaway and her team prioritize patient education, ensuring that each individual understands their options and can make informed decisions about their body contouring journey.

Body contouring procedures at Aesthetic Plastic Surgery & Laser Center are performed in accredited surgical facilities, adhering to the highest standards of safety and care. The center’s location in Farmington Hills provides convenient access for patients throughout the Michigan area.

As the field of plastic surgery continues to evolve, Dr. Hardaway remains at the forefront, continually updating her skills and incorporating the latest advancements in body contouring techniques. This dedication to ongoing education and improvement ensures that patients receive the most current and effective treatments available.

The expanded body contouring services at Aesthetic Plastic Surgery & Laser Center reflect a growing trend in Michigan and nationwide. More individuals are seeking ways to refine their physique and address body concerns that diet and exercise alone cannot resolve. With a range of surgical and non-surgical options available, patients can choose the approach that best fits their lifestyle and goals.

Prospective patients interested in learning more about body contouring options in Michigan are encouraged to schedule a consultation with Dr. Hardaway. During these personalized sessions, individuals can discuss their goals, learn about suitable procedures, and develop a tailored treatment plan.

As body contouring continues to gain popularity in Michigan, Aesthetic Plastic Surgery & Laser Center, Michelle Hardaway M.D. remains committed to providing exceptional results and compassionate care. With a focus on safety, natural-looking outcomes, and patient satisfaction, the center stands as a leading choice for those seeking to enhance their appearance through body contouring procedures.

For more information please contact Michelle Hardaway, M.D. at (248) 221-1957.

About Aesthetic Plastic Surgery & Laser Center, Michelle Hardaway M.D.:

Aesthetic Plastic Surgery & Laser Center, led by Dr. Michelle Hardaway, is a premier plastic surgery practice located in Farmington Hills, Michigan. With over two decades of experience, Dr. Hardaway is a board-certified plastic surgeon and a Fellow of the American College of Surgeons. The center offers a wide range of cosmetic and reconstructive procedures, including body contouring, breast surgery, facial rejuvenation, and non-surgical treatments. Committed to patient safety and satisfaction, Aesthetic Plastic Surgery & Laser Center provides personalized care and state-of-the-art techniques to help patients achieve their aesthetic goals.

Media Contact
Company Name: Aesthetic Plastic Surgery & Laser Center, Michelle Hardaway M.D.
Contact Person: Dr. Michelle Hardaway
Email: Send Email
Phone: (248) 221-1957
Address:27920 Orchard Lake Rd.
City: Farmington Hills
State: MI, 48334
Country: United States
Website: https://michellehardawaymd.com/

The Flower Mound Look: Chic, Modern, and Defined by Wise Glass’s Frameless Showers

Flower Mound now sees clearly how Wise Glass is revolutionizing the concept of the modern bathroom with its stunning frameless shower enclosures. “The Flower Mound Look,” characterized by its sleek sophistication and emphasis on light and space, is being rapidly adopted by homeowners who understand that these installations are design statements that elevate the entire home. Wise Glass achieves this transformation with its meticulous attention to detail, from precise measurements to flawless, watertight installation, ensuring both enduring quality and a bespoke finish tailored to each client’s unique vision.

“Flower Mound is a trendsetter when it comes to modern home design,” states Kevin Wisecarver of Wise Glass LLC. “Our frameless showers perfectly align with the city’s overall shift towards sophisticated and minimalist aesthetics. We’re constantly innovating, and exploring new glass options to offer a truly customized look. It’s not enough to just meet current trends, we strive to anticipate what’s next to ensure that Wise Glass stays ahead of the curve.”

This drive for excellence is a perfect match for Flower Mound’s own spirit. As it fosters a dynamic environment for economic development alongside its treasured small-town character, Flower Mound appreciates how businesses like Wise Glass contribute to its growth. Wise Glass is a great example of a company that’s doing well by doing good. Their Flower Mound frameless shower doors are becoming a sought-after upgrade, adding value to properties and contributing to the overall desirability of the town. They’re helping to shape a community that is both beautiful and built to last, which is a boon for economic development. It’s a real win-win where homeowners get the gorgeous bathrooms they’ve always dreamed of, and the town benefits from a successful local business that’s contributing to its growth. Flower Mound clearly sees the value in that kind of partnership and is better for it.

Wise Glass offers a wide array of glass solutions for the home, far beyond their signature frameless enclosures, which are becoming the most popular choice for shower doors in Flower Mound. Their expertise extends to custom mirrors, glass railings, and even wine cellars, all crafted with the same meticulous attention to detail. They are also a trusted source for commercial projects, providing storefronts, office partitions, and other glass installations for businesses throughout the area. Their diverse portfolio showcases their versatility and commitment to serving a wide range of needs in the community.

To learn more about how Wise Glass is enhancing Flower Mound homes with their exquisite glass installations, visit their website at https://www.wiseglassllc.net/.

Media Contact
Company Name: Wise Glass LLC
Contact Person: Kevin Wisecarver
Email: Send Email
Phone: 682-688-8815
Address:4100 Haltom Rd. Suite G
City: Haltom City
State: TX
Country: United States
Website: https://wiseglassllc.net/near-me/shower-doors-haltom-city-tx/

A Legacy Built on Reliability: Jordan Disposal Celebrates 100+ Years in Joplin

Jordan Disposal marks a historic milestone this year, celebrating over 100 years of continuous operation in Joplin, Missouri.

Jordan Disposal marks a historic milestone this year, celebrating over 100 years of continuous operation in Joplin, Missouri. This enduring legacy is a testament to the company’s unwavering commitment to providing reliable and essential waste management services to the community. From its humble beginnings to its current position as a leading provider in the region, Jordan Disposal has consistently adapted to the evolving needs of Joplin residents and businesses while upholding its core values of integrity and customer satisfaction.

“Building a cleaner Joplin isn’t just about the past but the future,” stated Michelle Murphy of Jordan Disposal. “While we’re immensely proud of our history, we’re equally focused on embracing innovation and sustainable practices. We’re investing in new technologies and exploring more environmentally sound solutions to ensure we can meet the waste management challenges of tomorrow.”

For over a century, Jordan Disposal has remained a cornerstone of the Tri-State area’s waste management infrastructure, consistently delivering reliable and efficient solutions. This legacy of service is intrinsically linked to the company’s various well-regarded offerings, including its popular roll-off service in Joplin, which has adapted and expanded to meet the evolving needs of the region. The company’s expertise extends to affordable dumpster rentals, efficient construction waste disposal, and demolition services, encompassing not just Joplin, MO, but also Galena and neighboring communities. The 2011 establishment of the Galena Construction & Demolition Landfill further enhanced Jordan Disposal’s capabilities, offering an environmentally conscious and cost-effective solution for managing a wide range of materials. A dedicated and knowledgeable team assists clients in determining the ideal dumpster size, ensuring a seamless experience for projects of any scale, be it a home cleanout, a major construction undertaking, or anything in between. This client-centric approach reinforces the company’s reputation as a trusted waste management leader.

Jordan Disposal is known for its dependable service and commitment to customer satisfaction. Their dumpster rental service features various container sizes, ensuring the perfect fit for any project’s scope. They offer flexible rental periods and prompt, reliable delivery and pickup, to streamline the waste disposal process for their customers. Furthermore, their transparent pricing structure ensures customers understand the upfront costs, with no hidden fees.

To learn more about Jordan Disposal’s comprehensive waste management services and explore its dumpster rental options, visit the company website at https://jordandisposal.com/. There, one can find detailed information on container sizes, pricing, and service areas and request a quote for their specific needs.

Media Contact
Company Name: Jordan Disposal
Contact Person: Mads Gisselbaek
Email: Send Email
Phone: (417) 624-4469
Address:1040 E Front St
City: Galena
State: KS
Country: United States
Website: https://jordandisposal.com/

Chronic Pain Therapeutics Market Size in the 7MM is anticipated to increase by 2034 and according to DelveInsight

DelveInsight’s “Chronic Pain Market Insights, Epidemiology and Market Forecast – 2034” report delivers an in-depth understanding of the Chronic Pain, historical and forecasted epidemiology as well as the Chronic Pain market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Unlock key insights into the Chronic Pain Market! Download DelveInsight’s comprehensive report to explore market trends, pipeline analysis, and emerging therapies @ Chronic Pain Market Size

Key Takeaways from the Chronic Pain Market Report

In November 2024:- Evon Medics LLC- The overarching goal of this study phase, Phase II component is to perform a randomized clinical trial of the refined Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain [CBOT-Pain (or CBOT-P)] from Phase I, compared to sham Computerized Chemosensory-Based Orbitofrontal Networks Training (CBOT) in Chronic Low Back Pain (CLBP) to determine its short- and long-term effectiveness on Pain, Negative Affect (NA), Cognition and Cortical Brain Structure (PACS), long-term safety, and indications.
In November 2024:- Hanmi Pharmaceutical Company Limited- A Randomized, Double-blind, Active-controlled, Non-inferiority, Multicenter Phase III Study to Evaluate the Efficacy and Safety of HCP1004 as compared to RLD2401 in Chronic Low-Back Pain Patients.
The total 7MM Chronic Pain Prevalent Cases in 2023 US accounted the highest cases.
Among the EU4 and the UK, the highest number of Chronic Pain prevalent cases were observed in the UK ~ 30%.
Prevalence of chronic pain increased with age and was higher among those in age group between 45-64 years.
Approximately 70% of chronic pain cases in the United States in 2023 fall within the category of moderate to severe severity-specific cases.
The Chronic Pain Companies such as AbbVie, Paradigm Biopharmaceuticals Ltd., Noven Pharmaceuticals, Pfizer, Anika Therapeutics, Biogen, Tonix Pharmaceuticals, Taiwan Liposome Company, Centrexion Therapeutics, Braeburn Pharmaceuticals, Regeneron, Teva Pharmaceuticals, Mitsubishi Tanabe Pharma Corporation, Vertanical GmbH, and others.
Promising Chronic Pain Therapies such as Secukinumab, AbobotulinumtoxinA, Rexlemestrocel-L + HA mixture, IncobotulinumtoxinA, Retatrutide, and others.

Stay ahead in the competitive landscape of the Chronic Pain Market. Access DelveInsight’s in-depth market analysis and strategic insights today! Click here for more @ Chronic Pain Treatment Market Size

Chronic Pain Epidemiology Segmentation in the 7MM

Total Chronic Pain Prevalent Cases
Total Chronic Pain Diagnosed Cases
Chronic Pain Severity-specific Cases
Chronic Pain Age-specific Cases
Chronic Pain Cause-specific Cases

Download the report to understand which factors are driving Chronic Pain epidemiology trends @ Chronic Pain Prevalence

Chronic Pain Marketed Drugs

JOYCLU (diclofenac etalhyaluronate sodium): Seikagaku Corporation/Chiltern International

JOYCLU is a formulation in which hyaluronic acid and diclofenac (an anti-inflammatory drug) are chemically bound using Seikagaku’s proprietary technology. It is designed to release diclofenac by hydrolysis in the joint. Improvement of symptoms of osteoarthritis (knee joint and hip joint) is expected by administering JOYCLU into the joint cavity once every 4 weeks. JOYCLU is the first joint function improvement agent in Japan to treat osteoarthritis of the hip joint.

ZILRETTA (triamcinolone acetonide extended-release injectable suspension): Pacira BioSciences

ZILRETTA (triamcinolone acetonide extended-release injectable suspension) is an intra-articular injection to manage osteoarthritis pain in the knee. ZILRETTA is Flexion’s novel, proprietary, sustained-release formulation composed of triamcinolone acetonide (TA) embedded in a biodegradable PLGA matrix that extends residence time in the joint for the treatment of mild-to-moderate OA of the knee. ZILRETTA received approval from the FDA on October 2017.

Chronic Pain Emerging Drugs

ZILOSUL (pentosan polysulfate sodium): Paradigm Biopharmaceuticals.

Pentosan polysulfate sodium (PPS) is a semi-synthetic drug manufactured from the wood chips of European beech trees. Extracted glucuronoxylans are sulfated to produce a negatively charged product that mimics glycosaminoglycans (GAGs). GAGs are complex carbohydrates that play a regulatory role in the body through interacting with proteins involved with inflammation. Key features of PPS activity are its anti-inflammatory and tissue regenerative properties, as well as its mild anti-thrombotic activity.

TNX-102 SL: Tonix Pharmaceuticals

TNX-102 SL, a sublingual tablet with 2.8 mg of cyclobenzaprine HCl, is taken nightly to treat fibromyalgia. Its rapid absorption and reduced production of a long-lasting active metabolite enhance its effectiveness. This patented formulation optimizes cyclobenzaprine delivery to improve sleep quality and minimize residual effects. TNX-102 SL, a centrally-acting analgesic, eases pain by enhancing sleep. It’s currently in mid-Phase III development for fibromyalgia management.

Discover the future of Chronic Pain Treatments with DelveInsight’s latest market report. Get expert insights and forecasts—download now! @ Chronic Pain Market Drivers and Barriers

Chronic Pain Drugs Market

Currently, several types of medications are being used in the management of chronic pain, including acetaminophen, ibuprofen, aspirin, COX-2 inhibitors, antimigraine medications, sedatives, opioids, and antidepressants. Nonpharmacologic treatments for chronic pain can include exercise, physical therapy, counseling, electrical stimulation, biofeedback, acupuncture, hypnosis, chiropractic medicine, and other treatments. There are several approved drugs for the treatment of chronic pain such as EMGALITY (galcanezumab-gnlm), AIMOVIG (erenumab), and AJOVY (fremanezumab), among others.

Chronic Pain Market Outlook

Key Chronic Pain Companies such as Paradigm Biopharmaceuticals, Centrexion Therapeutics, Tonix Pharmaceuticals, and others are evaluating their lead candidates in different stages of clinical development, respectively. They aim to investigate their products for the treatment of Chronic Pain. According to DelveInsight’s analysis, the Chronic Pain Market Growth is expected to be mainly driven by increasing Chronic Pain Prevalence, rise in awareness and access to treatment, alternative options (such as a novel therapeutic agent) to addictive opioids, holistic approach, efforts by the organization and upsurge in the geriatric population.

Explore the dynamics of the Chronic Pain Market with DelveInsight. From market size to emerging drugs—find it all in our latest report. Read now! @ Chronic Pain Ongoing Clinical Trials Analysis

Scope of the Chronic Pain Market Report

Coverage- 7MM
Study Period- 2020-2034
Chronic Pain Companies- AbbVie, Paradigm Biopharmaceuticals Ltd., Noven Pharmaceuticals, Pfizer, Anika Therapeutics, Biogen, Tonix Pharmaceuticals, Taiwan Liposome Company, Centrexion Therapeutics, Braeburn Pharmaceuticals, Regeneron, Teva Pharmaceuticals, Mitsubishi Tanabe Pharma Corporation, Vertanical GmbH, and others.
Chronic Pain Therapies- Secukinumab, AbobotulinumtoxinA, Rexlemestrocel-L + HA mixture, IncobotulinumtoxinA, Retatrutide, and others.
Chronic Pain Competitive Intelligence Analysis: SWOT analysis and Market entry strategies
Chronic Pain Unmet Needs, KOL’s views, Analyst’s views, Chronic Pain Market Access and Reimbursement

Table of Content

1 Key Insights

2 Report Introduction

3 Chronic Pain Market Overview at a Glance

4 Executive Summary of Chronic Pain

5 Key events

6 Disease Background and Overview

7 Epidemiology and Patient Population

8 Patient Journey

9 Marketed Products

10 Emerging Therapies

11 Chronic Pain: The Seven Major Markets Analysis

12 SWOT Analysis

13 Unmet Needs

14 KOL Views

15 Market Access and Reimbursement

16 Appendix

17 DelveInsight Capabilities

18 Disclaimer

19 About DelveInsight

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/report-store/lactose-intolerance-market

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Chronic Pain Therapeutics Market Size in the 7MM is anticipated to increase by 2034 and according to DelveInsight

Molecular Biology Enzymes and Kits & Reagents Industry Outlook, Current Growth, New Opportunities, Business Scenario, Size, Scope, Key Segments And Forecast

“The global molecular biology enzymes and kits & reagents market is highly consolidated. Key players in the molecular biology enzymes and kits & reagents market include Thermo Fisher (US), Merck (Germany)”

Browse 145 market data Tables and 36 Figures spread through 272 Pages and in-depth TOC on “Molecular Biology Enzymes & Kits & Reagents Market by Product (Kit, Reagent, Enzyme), Application (PCR, Sequencing, Epigenetic, Synthetic Biology), End user (Research Institutes, Pharma & Biotech Company, Hospitals) and Region – Global Forecast to 2026

According to the new market research report “Molecular Biology Enzymes and Kits & Reagents Market by Product (Kit, Reagent, Enzyme), Application (PCR, Sequencing, Epigenetic, Synthetic Biology), End user (Research Institutes, Pharma & Biotech Company, Hospitals) and Region – Global Forecast to 2026”, published by MarketsandMarkets™, the global market is projected to USD 29.7 billion by 2026 from USD 15.3 billion in 2021, at a CAGR of 14.2% during the forecast period.

Browse in-depth TOC on “Molecular Biology Enzymes and Kits & Reagents Market”

145 – Tables

36 – Figures

272 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=164131709

The Growth in the molecular biology enzymes and kits & reagents market is driven by factors such as increased research activities and R&D investments in the life science industry, rising number of genome projects, technological advancements in the life science industry, and rising incidence of genetic disorders.

The kits & reagents segment accounted for the largest share of the product segment in the molecular biology enzymes and kits & reagents market in 2020.

Based on products, the molecular biology enzymes and kits & reagents market is segmented into enzymes and kits & reagents. The kits & reagents segment accounted for the largest share of 85.9% of the global molecular biology enzymes and kits & reagents market in 2020. The large share of this segment can primarily be attributed to the repeat purchase of these single-use products. This segment is also expected to grow at the highest rate owing to its wide applications by pharmaceutical & biotechnology companies.

The polymerase chain reaction (PCR) segment accounted for the largest share of the application segment in the molecular biology enzymes and kits & reagents market in 2020

Based on applications, the global molecular biology enzymes and kits & reagents market is segmented into polymerase chain reaction (PCR), sequencing, cloning, epigenetics, restriction digestion, synthetic biology, and other applications (mutagenesis, in vitro transcription, and molecular labeling & detection). The polymerase chain reaction (PCR) segment accounted for the largest share of 28.3% of the molecular biology enzymes and kits & reagents market in 2020, mainly due to the low cost of PCR equipment, the extensive use of PCR equipment by a majority of end users, and the increasing use of PCR for molecular diagnostic assays in hospitals and clinics.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=164131709

The Asia Pacific region is the fastest-growing region of the molecular biology enzymes and kits & reagents market in 2020.

The market in the APAC is expected to grow at the highest rate during the forecast period. Growth in the APAC market is driven by increasing government interest in the biomedical & biotechnology industries, the presence of bio-clusters in India and China, and the growing outsourcing of clinical research activities to Asian countries.

The global molecular biology enzymes and kits & reagents market is highly consolidated. Key players in the molecular biology enzymes and kits & reagents market include Thermo Fisher (US), Merck (Germany), Illumina (US), QIAGEN (Netherlands), New England Biolabs (US), Promega (US), Agilent (US), Roche (Switzerland), Takara Bio (Japan), Bio Basic (Canada), Jena Bioscience (Germany), Molecular Biology Resources (US), Bio-Rad Laboratories, Inc. (US).

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=164131709

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/molecular-biology-enzymes-kits-reagents-market-164131709.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Molecular Biology Enzymes and Kits & Reagents Industry Outlook, Current Growth, New Opportunities, Business Scenario, Size, Scope, Key Segments And Forecast

ABSSSI Therapeutics Market Size in the 7MM is anticipated to increase by 2034 and according to DelveInsight

DelveInsight’s “Acute Bacterial Skin and Skin Structure Infections Market Insights, Epidemiology and Market Forecast – 2034” report delivers an in-depth understanding of the Acute Bacterial Skin and Skin Structure Infections, historical and forecasted epidemiology as well as the Acute Bacterial Skin and Skin Structure Infections market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Unlock key insights into the ABSSSI Market! Download DelveInsight’s comprehensive report to explore market trends, pipeline analysis, and emerging therapies @ ABSSSI Market Size

Key Takeaways from the Acute Bacterial Skin and Skin Structure Infections Market Report

In November 2024:- MicuRx- The purpose of this study is to determine whether MRX-I is as safe and effective as Linezolid in the treatment of adult patients with acute bacterial skin and skin structure infections
The highest rate of MRSA hospitalization was among the elderly—360.8 MRSA stays per 100,000 patients over 65 years of age which was more than three times higher for any other age group, 114.7 stays for infants, 19.2 for 1- to 17-year-olds, 58.1 for 18- to 44-year-olds, and 111.5 for 45- to 64-year-olds per 100,000.
As per secondary analysis, ABSSSI accounted for almost 870,000 hospital admissions in the United States in 2004 which represents an increase of almost 30% in the incidence of this diagnosis over a 4-year period.
Among nearly 5 million adult ABSSSI hospital admission, with admissions increasing 17.3% from 2005-2011. ABSSSI patients were primarily male (50.8%), white (60.3%), mean age 55.7 years.
According to DelveInsight’s analysis, the incidence of ABSSSI Infection is higher in men than women.
As per analysis, the microorganisms isolated most frequently from SSTIs were Staphylococcus aureus (29.2%), Pseudomonas aeruginosa (11.9%), E. coli (8.9%) and Enterococcus faecalis (7.4%).
The leading Acute Bacterial Skin and Skin Structure Infections Companies such as Melinta Therapeutics, LLC, Merck, Pfizer, Allergan, Paratek Pharmaceuticals, Cumberland Pharmaceuticals, Teva Pharmaceuticals, and others.
Promising Acute Bacterial Skin and Skin Structure Infections Therapies such as Contezolid acefosamil, Rifaquizinone (TNP-2092), and others.

Stay ahead in the competitive landscape of the ABSSSI Market. Access DelveInsight’s in-depth market analysis and strategic insights today! Click here for more @ ABSSSI Treatment Market Size

Acute Bacterial Skin and Skin Structure Infections Epidemiology Segmentation in the 7MM

Total Incident Cases of ABSSSI community/hospital
Acute Bacterial Skin and Skin Structure Infections Age-specific Incident Cases
Acute Bacterial Skin and Skin Structure Infections Gender-specific Incident Cases
Acute Bacterial Skin and Skin Structure Infections Pathogen-specific Incident Cases

Download the report to understand which factors are driving ABSSSI epidemiology trends @ ABSSSI Prevalence

ABSSSI Marketed Drugs

DALVANCE (dalbavancin) : ABBVIE /Durata Therapeutics

DALVANCE (dalbavancin), developed by Durata Therapeutics, represents a groundbreaking therapy addressing the root cause of ABSSSI. Approved by the FDA in May 2014, DALVANCE is an intravenous long-acting lipoglycopeptide antibiotic. Its mechanism of action involves targeting cell wall synthesis in Gram-positive bacteria by binding to the D-alanyl-D-alanine terminus of lipid II, a key precursor in this process. Effective against a broad spectrum of Gram-positive bacteria, including MRSA and Streptococcus pyogenes, DALVANCE exhibits bactericidal activity.

ORBACTIV: Melinta Therapeutics

ORBACTIV, a product of The Medicines Company (now part of Melinta Therapeutics), represents a significant breakthrough in ABSSSI treatment. FDA-approved, it offers a novel approach to combating Gram-positive bacterial infections by inhibiting bacterial cell wall synthesis, particularly through binding to the peptidoglycan precursor lipid II. With demonstrated efficacy against various Gram-positive pathogens, including MRSA, ORBACTIV stands out for its unique pharmacokinetic profile, enabling once-daily dosing. This convenience not only simplifies treatment regimens but also holds the potential to enhance patient compliance and improve clinical outcomes in ABSSSI management.

Emerging ABSSSI Drugs

MRX-4: MicuRx

MRX-4 is an injectable new oxazolidinone antibacterial agent, for the treatment of multidrug-resistant (MDR) which exhibits potent activity against gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), and penicillin-resistant Streptococcus pneumoniae (PRSP). In September 2018, the US FDA granted qualified infectious disease product status (QIDP) and fast track designation to contezolid acefosamil for the treatment of acute bacterial skin and skin structure infections (ABSSSI). Currenty, the drug is in Phase III of clinical development.

ZEVTERA (ceftobiprole): Basilea Pharmaceutica

ZEVTERA, developed by Basilea Pharmaceutica, is an intravenous cephalosporin antibiotic with rapid bactericidal activity against a broad spectrum of bacteria, including MSSA, MRSA, and susceptible Pseudomonas spp. It is currently approved for the treatment of hospital-acquired pneumonia. In August 2019, positive topline results from the TARGET study were reported, followed by similarly favorable outcomes from the ERADICATE study in June 2022. Subsequently, in April 2024, the US FDA granted approval for the New Drug Application (NDA) of ceftobiprole. This approval encompasses treatment indications for Staphylococcus aureus bacteremia (SAB), including right-sided infective endocarditis, acute bacterial skin and skin structure infections (ABSSSI), as well as community-acquired bacterial pneumonia (CABP).

Discover the future of ABSSSI Treatments with DelveInsight’s latest market report. Get expert insights and forecasts—download now! @ ABSSSI Market Drivers and Barriers

Acute Bacterial Skin and Skin Structure Infections Treatment Market

ABSSSI treatment aims to alleviate symptoms, enhance quality of life, halt disease progression, and prevent recurrence. Initial management, per IDSA guidelines, often involves oral antibiotics effective against streptococci for typical cellulitis cases. However, the prevalence of MRSA has led to a reevaluation of treatment strategies. Major treatment options for mild cases of non-purulent infections include penicillin, amoxicillin, amoxicillin-clavulanate, dicloxacillin, cephalexin, and clindamycin.

Acute Bacterial Skin and Skin Structure Infections Drugs Market Landscape

The Acute Bacterial Skin and Skin Structure Infections drugs market for treatments targeting Acute Bacterial Skin and Skin Structure Infections (ABSSSI) is xperiencing notable growth, driven by the increasing incidence of these infections and the rising prevalence of antibiotic-resistant bacteria. Innovations in antibiotic therapies, including novel agents and combination therapies, are expanding treatment options and fueling market expansion. Additionally, the growing focus on personalized medicine and rapid diagnostic tools is enhancing the management of ABSSSI. Increased investment in research and development by pharmaceutical companies and the expanding market for advanced healthcare solutions contribute to the sector’s robust growth. As healthcare systems grapple with the challenges of resistant infections, the demand for effective ABSSSI treatments is expected to continue rising.

Explore the dynamics of the ABSSSI Market with DelveInsight. From market size to emerging drugs—find it all in our latest report. Read now! @ ABSSSI Ongoing Clinical Trials Analysis

Scope of the Acute Bacterial Skin and Skin Structure Infections Market Report

Coverage- 7MM
Study Period- 2020-2034
Acute Bacterial Skin and Skin Structure Infections Companies- Melinta Therapeutics, LLC, Merck, Pfizer, Allergan, Paratek Pharmaceuticals, Cumberland Pharmaceuticals, Teva Pharmaceuticals, and others.
Acute Bacterial Skin and Skin Structure Infections Therapies- Contezolid acefosamil, Rifaquizinone (TNP-2092), and others.
Acute Bacterial Skin and Skin Structure Infections Competitive Intelligence Analysis: SWOT analysis and Market entry strategies
Acute Bacterial Skin and Skin Structure Infections Unmet Needs, KOL’s views, Analyst’s views, Acute Bacterial Skin and Skin Structure Infections Market Access and Reimbursement

Table of Content

1. Key Insights

2. Report Introduction

3. Acute Bacterial Skin and Skin-Structure Infection (ABSSSI) Market Overview at a Glance

4. Epidemiology and Market Methodology

5. Executive Summary of ABSSSI

6. Key Event

7. Disease Background and Overview

8. Epidemiology and Patient Population

9. Patient Journey

10. Marketed Therapies

11. Emerging Therapies

12. ABSSSI: Seven Major Market Analysis

13. Key Opinion Leaders’ Views

14. SWOT Analysis

15. Unmet Needs

16. Market Access and Reimbursement

17. Appendix

18. Bibliography

19. Acronyms and Abbreviations

20. Disclaimer

21. About DelveInsight

About Us

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/report-store/lactose-intolerance-market

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: ABSSSI Therapeutics Market Size in the 7MM is anticipated to increase by 2034 and according to DelveInsight

Technology Landscape, Trends and Opportunities in Satellite Communication Equipment Market

“The technologies in the global satellite communication equipment market have undergone significant changes in recent years, with a notable shift from SOTM/COTM technology to SOTP technology.”

The technologies in the global satellite communication equipment market have undergone significant changes in recent years, with a notable shift from SOTM/COTM technology to SOTP technology.

SOTP (Satellite-On-The-Pause) technology offers several advantages over traditional SOTM (Satellite-On-The-Move) and COTM (Communications-On-The-Move) systems. By allowing satellite communication terminals to establish connections while stationary, SOTP enables more stable and higher bandwidth connections, particularly in remote or challenging environments where constant movement may disrupt signal quality. Additionally, SOTP systems are often more cost-effective, as they require less complex tracking and positioning mechanisms than their mobile counterparts.

Download sample by clicking on https://www.lucintel.com/technology-satellite-communication-equipment-market.aspx

Viasat, SES S.A., Intelsat, Telesat, EchoStar, L3Harris Technologies are among the major technology providers in the satellite communication equipment market.

Lucintel, a leading global management consulting and market research firm with over 1,000 clients worldwide, has analyzed the technologies used in satellite communication equipment market and has now published a comprehensive research report titled “Technology Landscape, Trends and Opportunities in the Global Satellite Communication Equipment Market 2024-2030”. This report analyzes technology maturity, degree of disruption, competitive intensity, market potential, and other parameters of various technologies in the Satellite Communication Equipment Market technology market.

The study includes trends and forecast for the technology trends in the Satellite Communication Equipment Market by end use industry, technology, and region as follows: Technology Readiness by Technology Type Competitive Intensity and Regulatory Compliance Disruption Potential by Technology Type Satellite Communication Equipment Market Trend and Forecast by Technology [Shipment Analysis by Value from 2018 to 2030]: • SOTM/COTM and SOTP Satellite Communication Equipment Market Trend and Forecast by End Use Industry • Commercial • Government & Defense Satellite Communication Equipment Market by Region [Shipment Analysis by Value from 2018 to 2030]: • North America • Europe • Asia Pacific • The Rest of the World Latest Developments and Innovations in the Satellite Communication Equipment Technologies Companies / Ecosystems Strategic Opportunities by Technology Type

A more than 150-pages research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link helpdesk@lucintel.com.

About Lucintel

Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

Contact: Roy Almaguer Lucintel Dallas, Texas, USA Email: roy.almaguer@lucintel.com Tel. +1 972.636.5056

Explore Our Latest Publications

Technology Landscape, Trends and Opportunities in the Global Electric Vehicle Battery Market

Technology Landscape, Trends and Opportunities in the Global Electric Vehicle Motor Market

Technology Landscape, Trends and Opportunities in the Global Guidewire Market

Technology Landscape, Trends and Opportunities in the Global Hip Replacement Market

Technology Landscape, Trends and Opportunities in the Global Implantable Device Market

Media Contact
Company Name: Lucintel
Contact Person: Roy Almaguer
Email: Send Email
Phone: 972.636.5056
Address:8951 Cypress Waters Blvd., Suite 160
City: Dallas
State: TEXAS
Country: United States
Website: https://www.lucintel.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Technology Landscape, Trends and Opportunities in Satellite Communication Equipment Market

24HrDOC Celebrates Success as One of the Nation’s Leading Telemedicine Services

Convenient, Patient-Centric Care

24HrDOC combines the convenience of telehealth services with the personalized care patients expect from in-person visits. Whether you need a quick online consultation, a telemedicine prescription, or ongoing treatment, 24HrDOC is designed to meet your virtual healthcare needs easily and quickly. Patients can choose their preferred communication method — video, phone, or chat — for ultimate flexibility.

Expanding Access to Essential Healthcare Services

With a focus on providing comprehensive telemedicine care, 24HrDOC offers treatment for conditions across multiple categories, including:

Common Medical Conditions: Strep throat, sinus infections, and more.
Men’s and Women’s Health Services: Addressing hair loss, period delay, and other specialized needs.
Dermatology Consultations: Acne, psoriasis, scabies, and other skin-related concerns.
Mental Health Support Online: Supporting patients with resources to quit smoking and other behavioral goals.
Online STI Treatments: Discreetly treating conditions like chlamydia, gonorrhea, and genital herpes.

“With over 70% of patients facing barriers to accessing traditional care, our online doctor consultations ensure that everyone can connect with a qualified doctor from anywhere at any time,” Ayesha Khan added.

How It Works

The streamlined 24HrDOC process ensures fast telemedicine care:

Submit a Virtual Consultation Form: Share your medical history, symptoms, and concerns.
Receive a Personalized Online Treatment Plan: Get a customized plan from a licensed doctor within hours.
Prescription Delivery or Local Pickup: Pick up your telehealth prescription at your local pharmacy with no hidden fees.

Leading the Future of Telehealth

Since its inception, 24HrDOC has rapidly become a trusted name in online healthcare services. It provides over 40 medical treatments and is among the highest-rated online doctor platforms nationwide. With NCQA-accredited telemedicine and robust security measures, the platform prioritizes patient confidentiality and trust.

In addition to its affordable services, 24HrDOC is committed to innovation, offering advanced features like:

AI-Driven Symptom Checker: For faster and more accurate diagnostics.
Secure Online Medical Records: Ensuring patient information is always protected.

About 24HrDOC

24HrDOC is a premier telemedicine platform designed to provide affordable online healthcare to patients across the U.S. Offering treatments for a wide range of conditions, the platform eliminates barriers like copays, insurance, and long wait times. With NCQA accreditation and a mission to revolutionize healthcare, 24HrDOC connects patients with licensed doctors online anytime, anywhere.

To learn more, visit www.24hrdoc.com.

Media Contact
Company Name: 24hrDOC
Contact Person: Ayesha Khan, Medical Director
Email: Send Email
Phone: 1-866-203-4555
Address:3050 Post Oak Blvd
City: Houston
State: Texas
Country: United States
Website: https://www.24hrdoc.com

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: 24HrDOC Celebrates Success as One of the Nation’s Leading Telemedicine Services

Predictive Maintenance Market Latest Trends, Size, Share, Growth, Industry Analysis, Advance Technology And Forecast – 2029

“IBM (US), ABB (Switzerland), Schneider Electric (France), AWS (US), Google (US), Microsoft (US), Hitachi (Japan), SAP (Germany), SAS Institute (US), Software AG (Germany), TIBCO Software (US), Altair (US), Oracle (US), Splunk (US), C3.ai (US), Emerson (US), GE (US), Honeywell (US), Siemens (Germany), PTC (US), Dingo (Australia), Uptake (US), Samotics (Netherlands), WaveScan (Singapore).”

Predictive Maintenance Market Size, by Technology (Analytics, Data Management, AI, IoT Platform, Sensors), Technique (Vibration Analysis, Infrared Thermography, Oil analysis, Motor Circuit Analysis, Acoustic Monitoring) – Global Forecast to 2029.

The predictive maintenance market in the U.S. is rapidly evolving, driven by the need for improved operational efficiency and cost reduction. With aging infrastructure across various sectors, organizations are increasingly adopting predictive maintenance solutions to monitor equipment health and prevent failures before they occur. Integrating artificial intelligence (AI) and data analytics enhances these capabilities, allowing for real-time insights and better decision-making.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=8656856

Government initiatives, particularly within the Department of Defense, are pushing for advanced predictive maintenance solutions to ensure operational readiness and reduce unplanned maintenance costs. As industries like manufacturing, transportation, and energy recognize the benefits of predictive maintenance, investments in digital tools and technologies are expected to grow significantly.

Need to Maintain Infrastructure

In the U.S. market, aging infrastructure, facilities, and systems have been operational for a long time and require innovation to enhance their reliability and utility. Predictive maintenance technologies allow organizations to track their equipment’s condition in real-time and intervene before failure occurs. Such an approach minimizes any chances of breakages and, therefore, downtime and maintenance costs, which are crucial for resources. Using sophisticated sensors and analytical data, US firms can prolong the useful life of old assets while managing the servicing costs, boosting their operational readiness and sustainability.

Digital Replicas of Physical Assets can Enhance Monitoring

Digital twin technology presents a significant opportunity for the predictive maintenance market in the U.S. by creating virtual replicas of physical assets. This innovation allows companies to monitor real-time performance and operational conditions, leading to more accurate maintenance predictions.

Digital twins enable organizations to optimize maintenance schedules, lowering costs and extending asset lifespans. As more U.S. companies adopt this technology, they can enhance productivity and improve overall equipment reliability, driving growth in the predictive maintenance market and fostering a culture of proactive asset management.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=8656856

Government Initiatives and Technological Advancements

The U.S. Air Force uses artificial intelligence and data analytics to improve aircraft readiness with predictive maintenance techniques, like the Predictive Analytics and Decision Assistant (PANDA) solution. Operating costs associated with unscheduled maintenance currently stand at $90 billion annually for the Department of Defense (DOD). The DoD has been advocating for predictive maintenance with the hope of enhancing the efficiency in its operations and combating readiness problems which some of the military branches have started addressing by engaging in pilot programs and creating master plans to monitor outcomes effectiveness.

Impact of AI on Predictive Maintenance Market

By analyzing large volumes of maintenance data, AI can predict equipment failures before they occur, minimizing downtime and maintenance expenses. This is particularly crucial for industries like defense, where operational readiness is vital. In the U.S., where the population exceeds 345 million and businesses are increasingly reliant on technology, implementing AI-driven predictive maintenance can lead to significant growth. It supports just-in-time logistics, ensuring that necessary parts and repair crews are available when needed, thus streamlining operations and improving productivity across various sectors, including manufacturing and transportation.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=8656856

Challenges in the US Predictive Maintenance Market

Poor quality or incomplete data and dependence on legacy systems are significant challenges hindering the growth of the predictive maintenance market in the U.S. Inaccurate or inconsistent data can lead to faulty predictions, causing organizations to lose trust in predictive maintenance solutions. Many companies rely on legacy systems incompatible with modern predictive maintenance tools. Upgrading these systems can be expensive and complex, deterring organizations from adopting new technologies.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/operational-predictive-maintenance-market-8656856.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Predictive Maintenance Market Latest Trends, Size, Share, Growth, Industry Analysis, Advance Technology And Forecast – 2029